Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Operating Leases (2018 - 2025)

Health Catalyst's Operating Leases history spans 8 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 10.41% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $18.0 million, up 10.41%, while the annual FY2025 figure was $18.0 million, 10.41% up from the prior year.
  • Operating Leases reached $18.0 million in Q4 2025 per HCAT's latest filing, up from $15.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $23.1 million in Q1 2021 to a low of $15.1 million in Q3 2025.
  • Average Operating Leases over 5 years is $18.3 million, with a median of $18.0 million recorded in 2022.
  • The largest YoY upside for Operating Leases was 1578.76% in 2021 against a maximum downside of 17.71% in 2021.
  • A 5-year view of Operating Leases shows it stood at $20.2 million in 2021, then decreased by 11.0% to $18.0 million in 2022, then fell by 1.89% to $17.7 million in 2023, then dropped by 7.84% to $16.3 million in 2024, then increased by 10.41% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Operating Leases are $18.0 million (Q4 2025), $15.1 million (Q3 2025), and $15.9 million (Q2 2025).